Pinealon

Pinealon is a tripeptide bioregulator (Glu-Asp-Arg) developed at the St. Petersburg Institute of Bioregulation and Gerontology that primarily targets the central nervous system and pineal gland to support neuroprotection, cognitive function, and sleep regulation.

Its documented benefits include enhanced memory consolidation, improved mental clarity, and protection against age-related neuronal decline through the upregulation of neurotrophic factors like BDNF and antioxidant enzymes.

Key benefits identified in research and clinical protocols include:

• Cognitive Enhancement: Improves memory retention, attention span, and processing speed by supporting synaptic transmission and neuronal survival.
• Sleep and Circadian Regulation: Restores natural sleep-wake cycles and melatonin production, helping to alleviate insomnia and jet lag by resetting pineal gland function.
• Neuroprotection: Shields brain cells from oxidative stress, hypoxia, and neurotoxic damage, potentially slowing neurodegenerative conditions like Alzheimer’s and Parkinson’s.
• Mood and Stress Balance: Modulates neurotransmitters such as serotonin, dopamine, and GABA to reduce anxiety, stabilize mood, and lower cortisol levels during stress.

While generally well-tolerated with minimal side effects, Pinealon is not FDA-approved for human therapeutic use in the United States and is often categorized as a research peptide or available through specialized compounding pharmacies.

Most efficacy data stems from Russian clinical trials, with limited large-scale Western replication.